forxiga glp 1 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes Diabetes patients now have access

The Extracellular NADome Modulates Immune Responses

Kosugi S, Ban T, Akamizu T, Kohn LD

Reduced hunger and appetite trends Participants receiving the formula showed consistently lower hunger and craving scores during the late post-meal period

(PubMed) Anderson R, Oosthuizen R, Maritz R, Theron A, Van Rensburg AJ

MT-1 in subcutaneous implant formulation and documented significant increases in pain-free sun exposure time in EPP patients, with studies characterising reduced phototoxic reactions, improved quality of life, and clinically meaningful photoprotection in a patient population where even brief visible light exposure produces severe phototoxic pain